The strong revenue beat and 118% adjusted EBITDA growth signal accelerating profitability, but the EPS miss and negative operating cash flow (driven by tax timing) create a mixed picture. Watch for Q2 2026 sales contribution from the Delta 2 expansion and Netherlands Phase II ramp, which management expects to drive stronger 2H'26 results. The $6.4M share repurchase and improved debt terms (50bp rate cut, maturity extended to 2031) provide balance sheet support.
Price Chart
Executive Summary
Village Farms reported Q1 2026 revenue of $50.2M (+27% YoY) and GAAP EPS of $0.03 (vs consensus $0.02, a miss of -57.1% on the Street-quoted metric). Cannabis segment net sales grew 27% to $49.7M, international exports surged 171% to a record $14.6M, and adjusted EBITDA from continuing operations rose 118% to $9.9M. Despite the strong operational momentum, the EPS miss relative to consensus and negative operating cash flow of -$16.8M (driven by $15M in income tax payments) temper the bullish narrative.
Key Financial Metrics
Key Facts
- Consolidated net sales increased 27% YoY to $50.2M
- GAAP EPS from continuing operations: $0.03 basic, $0.02 diluted (consensus $0.02 — miss of -57.1% on Street metric)
- Cannabis segment net sales: $49.7M (+27% YoY), gross margin 43% (vs 39%)
- International export sales from Canada: record $14.6M (+171% YoY, +60% sequentially)
- Adjusted EBITDA from continuing operations: $9.9M (+118% YoY), margin 20% of sales
- Net income attributable to shareholders: $2.9M vs $(6.7M) loss in prior year period
- Cash flow used in operations: ($16.8M), including $15.0M in Canadian income tax payments
- Share repurchases of $6.4M in Q1; cash balance $50.5M (down from $81.2M at year-end)
- Delta 2 greenhouse expansion expected to add ~40 metric tonnes annualized production by 2027
- Netherlands Phase II facility expected to quintuple production to ~10 metric tonnes annually by end of 2026
Financial Impact
Revenue beat consensus by ~$2.4M (+5.0%), but EPS missed consensus by -57.1% on the Street-quoted metric. Adjusted EBITDA grew 118% YoY to $9.9M.
Risk Factors
- EPS miss of -57.1% vs consensus may pressure the stock near-term despite strong revenue growth
- Operating cash flow negative at -$16.8M, though partly due to $15M in tax payments
- Cash balance declined from $81.2M to $50.5M in Q1 due to capex, buybacks, and tax payments
- Canadian cannabis market remains competitive; market share position could erode
- U.S. cannabis rescheduling timeline uncertain despite executive order
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 press release from GlobeNewswire.
| Document | Accession Number |
|---|---|
| PRESS-RELEASE Data (Synthetic) | press-3291737 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 22, 2026 3d ago | 8-K | $2.79 | awaiting T+1 | — | $2.54 (−9.00%) |
Oct 22, 2026 4d ago | 8-K | $2.71 $2.58 | ▼ −4.98% | ▼ −4.46% | $2.54 (−6.32%) |
Sep 22, 2026 4w ago | Insider Cluster | $3.04 $3.12 | ▲ +2.80% | ▲ +2.88% | $2.54 (−16.35%) |
Sep 10, 2026 6w ago | 8-K | $2.86 $2.88 | ▲ +0.70% | ▼ −0.15% | $2.54 (−11.23%) |
Aug 10, 2026 11w ago | 8-K | $2.37 $2.43 | ▲ +2.53% | ▲ +2.85% | $2.54 (+7.12%) |
Aug 10, 2026 11w ago | Press Release | $2.37 $2.43 | ▲ +2.53% | ▲ +2.85% | $2.54 (+7.12%) |
Jul 22, 2026 13w ago | 8-K | $1.99 $1.95 | ▼ −2.01% | ▼ −0.78% | $2.54 (+27.58%) |
Jun 11, 2026 19w ago | Institutional Cluster | $2.08 $2.03 | ▼ −2.40% | ▼ −2.94% | $2.54 (+22.06%) |
Jun 8, 2026 20w ago | 8-K | $2.16 $2.09 | ▲ +3.24% | ▲ +2.95% | $2.54 (−17.54%) |
Jun 5, 2026 20w ago | 424B5 | $2.16 $2.09 | ▲ +3.24% | ▲ +2.95% | $2.54 (−17.54%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers